Adrenoceptor-related decrease in serum triglycerides is independent of PPARα activation

Area of Science:

• Endocrinology
• Metabolic Syndrome Research
• Molecular Biology

Background:

• Adrenoceptor (AR)-linked pathways are key in the stress response and linked to metabolic syndrome pathophysiology.
• Serum triglyceride (TG) dysregulation is a hallmark of metabolic syndrome.

Purpose of the Study:

• To investigate the role of adrenoceptor stimulation in regulating serum TG levels in mice.
• To elucidate the molecular mechanisms underlying TG regulation by AR agonists.

Main Methods:

• Activation of α1-ARs using phenylephrine (PH) and β1/2-ARs using isoprenaline (ISOP) in mice.
• Analysis of serum TG levels, hormone-sensitive lipase activity, and gene expression (Lpl, Nr4A, Dgat1, Mttp, Aadac, Cd36).
• Investigation of the hepatic insulin/PI3k/AKT/FoxO1 signaling pathway.

Main Results:

• Both PH and ISOP markedly reduced serum TG levels independently of PPARα activation.
• AR agonists activated hormone-sensitive lipase in white adipose tissue, increasing TG mobilization.
• Upregulation of key TG regulatory genes (Lpl, Nr4A, Dgat1, Mttp, Aadac, Cd36) was observed.
• AR stimulation inactivated the hepatic insulin/PI3k/AKT/FoxO1 pathway, impacting TG synthesis.

Conclusions:

• Stimulation of α1- and β1/2-ARs effectively reduces serum TG levels through multifaceted alterations in TG metabolism.
• The TG-lowering effect is mediated by PPARα-independent mechanisms involving TG synthesis, uptake, transport, hydrolysis, and clearance.